AMN Healthcare Reports Q1 2025 Financial Performance

AMN Healthcare’s Financial Performance Summary
AMN Healthcare Services, Inc. (NYSE: AMN) has reported its financial results for the first quarter of 2025, indicating a quarterly revenue of $690 million. Although there was a GAAP loss of $0.03 per share, the company achieved an adjusted EPS of $0.45.
Quarterly Financial Highlights
The financial highlights for the quarter reflect major considerations:
- Total Revenue: $690 million, which marks a decline of 16% year-over-year.
- Gross Profit: $198.1 million, representing a 23% decrease compared to the previous year.
- Net Loss: $1 million, equating to a loss of $0.03 per diluted share.
- Adjusted EBITDA: $64.2 million, with a significant year-over-year decline.
Business Highlights and Strategic Initiatives
During the quarter, AMN Healthcare witnessed fluctuating trends influenced by various market dynamics. The company highlighted several key initiatives:
- Significant growth in locum tenens and allied revenue exceeded expectations due to labor market disruptions.
- Coordination enhancements in SG&A management have led to effective operation leverage, improving the gross margin compared to initial guidance.
- AMN Healthcare was honored with a spot in Modern Healthcare’s 2025 Innovators Awards, showcasing the effectiveness of their WorkWise workforce technology.
- The operational cash flow was reported at $93 million, with debt reduction efforts achieving $60 million.
Looking Ahead: Q2 2025 Guidance
For the upcoming second quarter of 2025, AMN Healthcare has set an optimistic outlook while forecasting:
- Consolidated Revenue Estimate: $645 million to $660 million.
- Gross Margin Guidance: Between 28.5% and 29%.
- Adjusted EBITDA Margin Projection: Estimated at 7.8% to 8.3%.
Operational Insights
The company's financial decline can be attributed to reduced revenue within specific segments:
- Nurse and Allied Solutions: Generated $413 million, a fall of 20% year-over-year.
- Physician and Leadership Solutions: Registered revenue of $174 million, down by 8% year-over-year.
- Technology and Workforce Solutions: Achieved $102 million in revenue, marking a 9% decline from the previous year.
CEO Statement
Cary Grace, President and CEO of AMN Healthcare, stated, “The financial outcomes reflect increasing patient volumes from our clients and an accelerated market recovery that is favorably impacting our tech-driven solutions.” He emphasized the focus on market expansion powered by AMN’s diversified workforce solutions.
Frequently Asked Questions
1. What were AMN Healthcare's total revenues for the first quarter of 2025?
The company reported total revenues of $690 million for the first quarter of 2025.
2. How much did AMN Healthcare lose per share in Q1 2025?
AMN Healthcare reported a GAAP loss of $0.03 per share in Q1 2025.
3. What is the adjusted EPS for AMN as reported?
The adjusted EPS for the first quarter is $0.45.
4. How did AMN Healthcare's revenue compare year over year?
AMN's revenue fell by 16% compared to the same quarter in the previous year.
5. What are the projected revenues for the second quarter of 2025?
AMN Healthcare expects revenues to be between $645 million and $660 million for Q2 2025.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.